Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia

EClinicalMedicine. 2020 Jul 16:24:100467. doi: 10.1016/j.eclinm.2020.100467. eCollection 2020 Jul.
No abstract available